Mucodel Pharma LLC
2110 Rockglen Lane
The mission of Mucodel is to develop improved rescue therapies that are oromucosally administered. Mucodel’s proprietary Co-Gel technology allows for oromucosal administration of existing drugs that would not otherwise be amenable to oromucosal delivery. Mucodel’s Co-Gel platform enables more convenient products and offers tangible therapeutic benefits to patients.
Founder & CEO: Madhu Hariharan
Please click here for Mucodel's pipeline.